AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34058610 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (n = 55)
Number of subjects: 235
Study 32091610 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Cognitive Aid (MAX) used in scenarios (MAX+)
Number of subjects: 0
Study 32091610 — intervention group
Group type: COMPARATOR
Intervention: Memory and training alone (MAX‐)
Number of subjects: 0
Study 35210153 — intervention group
Group type: EXPERIMENTAL
Intervention: First stage of a planned 2-stage exchange
Number of subjects: 66
Study 35210153 — intervention group
Group type: COMPARATOR
Intervention: 1-stage exchange
Number of subjects: 66
Study 33161336 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated partial breast irradiation (APBI) using 3D-CRT and IG-IMRT
Number of subjects: 104
Study 33918616 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic continuous and interval training under hypoxia
Number of subjects: 20
Study 33918616 — intervention group
Group type: COMPARATOR
Intervention: Normoxic training
Number of subjects: 20
Study 32143649 — intervention group
Group type: EXPERIMENTAL
Intervention: Words format
Number of subjects: 234
Study 32143649 — intervention group
Group type: COMPARATOR
Intervention: Control (standard lab report)
Number of subjects: 234
Study 32143649 — intervention group
Group type: EXPERIMENTAL
Intervention: Graph format
Number of subjects: 234
Study 36370185 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged prophylactic antibiotic therapy (PAT) group (Group B)
Number of subjects: 120
Study 36370185 — intervention group
Group type: COMPARATOR
Intervention: No prolonged prophylactic antibiotic therapy group (Group A)
Number of subjects: 120
Study 33307682 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1-CYA (a GLP-1 analogue with cysteic acid at the third position)
Number of subjects: 0
Study 33307682 — intervention group
Group type: COMPARATOR
Intervention: Wild type GLP-1
Number of subjects: 0
Study 33453417 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time moderate-to-high-intensity exercise training (2 to 3 sessions per week for 3 months)
Number of subjects: 32
Study 33453417 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time moderate-to-high-intensity exercise training
Number of subjects: 32
Study 33453417 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 32
Study 32865282 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro fertilisation group (n = 198)
Number of subjects: 1619
Study 32865282 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 1421)
Number of subjects: 1619
Study 32865282 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-stimulated in vitro fertilisation
Number of subjects: 1619
Study 35662546 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 vaginal laser treatment
Number of subjects: 101
Study 34561665 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable partial denture (RPD)
Number of subjects: 215
Study 34561665 — intervention group
Group type: COMPARATOR
Intervention: Shortened dental arch (SDA)
Number of subjects: 215
Study 32036258 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal ropivacaine alone (Group C)
Number of subjects: 60
Study 32036258 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal ropivacaine + 5 μg dexmedetomidine (Group D)
Number of subjects: 60
Study 34397402 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet rich plasma (PRP) injection
Number of subjects: 60
Study 34397402 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (Control)
Number of subjects: 60
Study 32961126 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal airway used just before nasotracheal intubation (NTI) during mask ventilation
Number of subjects: 70
Study 32961126 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nasal airway used)
Number of subjects: 70
Study 36123418 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged mechanical ventilation (MV)
Number of subjects: 4809
Study 36123418 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter durations of mechanical ventilation (MV)
Number of subjects: 4809
Study 35279741 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy with apremilast and narrowband UVB
Number of subjects: 0
Study 35279741 — intervention group
Group type: COMPARATOR
Intervention: Narrowband UVB monotherapy
Number of subjects: 0
Study 35677371 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontics plus implant anchorage
Number of subjects: 90
Study 35677371 — intervention group
Group type: COMPARATOR
Intervention: Orthodontics alone
Number of subjects: 90
Study 32306091 — intervention group
Group type: EXPERIMENTAL
Intervention: Older patients (≥75 years) undergoing primary UKA
Number of subjects: 282
Study 35243631 — intervention group
Group type: EXPERIMENTAL
Intervention: $2 bill incentive
Number of subjects: 1267
Study 35243631 — intervention group
Group type: COMPARATOR
Intervention: Control group with no incentive
Number of subjects: 1267
Study 35243631 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-monetary incentive (customized pen/stylus)
Number of subjects: 1267
Study 35243631 — intervention group
Group type: EXPERIMENTAL
Intervention: First-class stamps
Number of subjects: 1267
Study 35243631 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk mail
Number of subjects: 1267
Study 34571463 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe weight loss (grade 2-3)
Number of subjects: 524
Study 34571463 — intervention group
Group type: COMPARATOR
Intervention: Non-severe weight loss
Number of subjects: 524
Study 36273083 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D3 (cholecalciferol) supplementation, weekly for six weeks
Number of subjects: 22
Study 32431062 — intervention group
Group type: EXPERIMENTAL
Intervention: p53 Immunohistochemistry (IHC)
Number of subjects: 970
Study 34521277 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus pomalidomide and dexamethasone
Number of subjects: 0
Study 34521277 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide and dexamethasone (control)
Number of subjects: 0
Study 34424533 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturisers from the first 2 weeks of life
Number of subjects: 200
Study 34424533 — intervention group
Group type: COMPARATOR
Intervention: Control group without moisturisers
Number of subjects: 200
Study 33220115 — intervention group
Group type: EXPERIMENTAL
Intervention: Training stop‐smoking practitioners to deliver support according to the NCSCT Standard Treatment Programme
Number of subjects: 502
Study 33220115 — intervention group
Group type: COMPARATOR
Intervention: Usual care (brief support and follow‐up)
Number of subjects: 502
Study 32703092 — intervention group
Group type: EXPERIMENTAL
Intervention: Online, synchronous video counseling
Number of subjects: 49
Study 32703092 — intervention group
Group type: COMPARATOR
Intervention: In-person counseling
Number of subjects: 49
Study 34178837 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin 8% patch
Number of subjects: 291
Study 34178837 — intervention group
Group type: COMPARATOR
Intervention: 5% Lidocaine patch
Number of subjects: 291
Study 34620774 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media-based community consultation (CC) using Facebook and Instagram advertisements
Number of subjects: 332081
Study 32669234 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational digital media activities
Number of subjects: 0
Study 32669234 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal care
Number of subjects: 0
Study 32669234 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise activities
Number of subjects: 0
Study 32669234 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily digital media activity
Number of subjects: 0
Study 32669234 — intervention group
Group type: EXPERIMENTAL
Intervention: Travel time
Number of subjects: 0
Study 35060967 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-flap (OF) technique using Er,Cr:YSGG laser
Number of subjects: 36
Study 35060967 — intervention group
Group type: COMPARATOR
Intervention: Flapless (FL) technique using Er,Cr:YSGG laser
Number of subjects: 36
Study 33886115 — intervention group
Group type: EXPERIMENTAL
Intervention: Dydrogesterone and doxycycline
Number of subjects: 188
Study 33886115 — intervention group
Group type: COMPARATOR
Intervention: Single antibiotic
Number of subjects: 188
Study 32841892 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity interventions for individuals with low interpersonal risks and concurrent protective psychological factors
Number of subjects: 227
Study 32841892 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interventions for individuals with high interpersonal risks and clinical symptoms
Number of subjects: 227
Study 32841892 — intervention group
Group type: EXPERIMENTAL
Intervention: Classes 1 and 2
Number of subjects: 227
Study 32841892 — intervention group
Group type: EXPERIMENTAL
Intervention: Class 1
Number of subjects: 227
Study 32841892 — intervention group
Group type: EXPERIMENTAL
Intervention: Class 3
Number of subjects: 227
Study 34762756 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking with Voices (novel intervention for supporting distressed voice-hearers)
Number of subjects: 5
Study 35770602 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint Mobilization
Number of subjects: 45
Study 35770602 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 45
Study 35770602 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 45
Study 32782170 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRHa) for 3 months before IVF
Number of subjects: 200
Study 32782170 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months before IVF
Number of subjects: 200
Study 32594783 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowered seat height by 5.08 cm below lower-leg length
Number of subjects: 50
Study 32594783 — intervention group
Group type: COMPARATOR
Intervention: Higher seat heights
Number of subjects: 50
Study 33687783 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra rapid lispro (URLi)
Number of subjects: 432
Study 33107418 — intervention group
Group type: COMPARATOR
Intervention: Δ9‐THC (1.19 mg/2 ml)
Number of subjects: 16
Study 36502500 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% hexylresorcinol
Number of subjects: 32
Study 36502500 — intervention group
Group type: COMPARATOR
Intervention: Topical 2% hydroquinone
Number of subjects: 32
Study 34418415 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound-guided treatment strategy
Number of subjects: 367
Study 34418415 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 367
Study 32962735 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannose supplementation at a total of 1-2 g mannose/kg b.w./d divided into 5 single doses
Number of subjects: 20
Study 36079841 — intervention group
Group type: EXPERIMENTAL
Intervention: MED‐02 (5 × 10^9 CFU/day)
Number of subjects: 100
Study 36079841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34083403 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg daily for 3 days followed by 250 mg daily for 12 days + Hydroxychloroquine 200 mg twice daily for 15 days
Number of subjects: 117
Study 34083403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 34083403 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin + Hydroxychloroquine
Number of subjects: 117
Study 32495498 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Friendly Community Initiative (BFCI) intervention
Number of subjects: 270
Study 32495498 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 270
Study 36052304 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/day)
Number of subjects: 75
Study 36052304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 33635829 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with PCOS
Number of subjects: 21292
Study 33635829 — intervention group
Group type: COMPARATOR
Intervention: Women without PCOS (control)
Number of subjects: 21292
Study 32638409 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein-low carbohydrate (HP-LC) meal
Number of subjects: 17
Study 32638409 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein-low fat (HP-LF) meal
Number of subjects: 17
Study 32638409 — intervention group
Group type: COMPARATOR
Intervention: STANDARD meal (55% carbohydrate, 30% fat, 15% protein)
Number of subjects: 17
Study 32638409 — intervention group
Group type: EXPERIMENTAL
Intervention: Food consumption (general intervention)
Number of subjects: 17
Study 32638409 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting proinsulin to insulin ratio
Number of subjects: 17
Study 35352698 — intervention group
Group type: EXPERIMENTAL
Intervention: Papilloguard (Noyan Pajouhan Biopharma)
Number of subjects: 218
Study 35352698 — intervention group
Group type: COMPARATOR
Intervention: Cervarix (GlaxoSmithKline)
Number of subjects: 218
Study 33783846 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hypnosis and TENS
Number of subjects: 72
Study 33783846 — intervention group
Group type: COMPARATOR
Intervention: TENS alone
Number of subjects: 72
Study 32844813 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implants (Type 1 ITI protocol)
Number of subjects: 13
Study 32844813 — intervention group
Group type: COMPARATOR
Intervention: Delayed implants (Type 4 ITI protocol)
Number of subjects: 13
Study 32844813 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 13
Study 35084323 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib
Number of subjects: 47
Study 34421796 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of GTN (5 mg GTN in 50 ml saline at a rate of 0.4 mg/h for 12.5 h/day for 2 days)
Number of subjects: 40
Study 34421796 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of 0.9% normal saline (NS) (total 50 ml/day at 4 ml/h for 12.5 h/day for 2 days)
Number of subjects: 40
Study 34027846 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended dairy (RDa; 4 servings/d)
Number of subjects: 46
Study 34027846 — intervention group
Group type: COMPARATOR
Intervention: Low dairy (LDa; ≤ 2 servings/d)
Number of subjects: 46
Study 33256841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort
Number of subjects: 6440
Study 33256841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort aged below 49 years
Number of subjects: 6440
Study 33256841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort aged above 65 years
Number of subjects: 6440
Study 33256841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort with comorbidities
Number of subjects: 6440
Study 33256841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) cohort without comorbidities
Number of subjects: 6440
Study 33256841 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID use in AS cohort
Number of subjects: 6440
Study 33256841 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressants in AS cohort
Number of subjects: 6440
Study 33108905 — intervention group
Group type: EXPERIMENTAL
Intervention: CFP stem
Number of subjects: 44
Study 33108905 — intervention group
Group type: EXPERIMENTAL
Intervention: Corail stem
Number of subjects: 44
Study 33108905 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 33879585 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 126
Study 32380135 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric tooth-brushing with NaF (group 2)
Number of subjects: 75
Study 32380135 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric tooth-brushing with SnF2 (group 3)
Number of subjects: 75
Study 32380135 — intervention group
Group type: EXPERIMENTAL
Intervention: Dab-on application of NaF (group 4)
Number of subjects: 75
Study 32380135 — intervention group
Group type: EXPERIMENTAL
Intervention: Dab-on application of SnF2 (group 5)
Number of subjects: 75
Study 32380135 — intervention group
Group type: COMPARATOR
Intervention: Artificial saliva control (group 1)
Number of subjects: 75
Study 33915006 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV)
Number of subjects: 57
Study 32650077 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltopectoral approach (DP)
Number of subjects: 85
Study 32650077 — intervention group
Group type: COMPARATOR
Intervention: Deltoid split approach (DS)
Number of subjects: 85
Study 35113322 — intervention group
Group type: EXPERIMENTAL
Intervention: LCS video decision aid including information on incidental findings
Number of subjects: 348
Study 35113322 — intervention group
Group type: COMPARATOR
Intervention: Control video decision aid
Number of subjects: 348
Study 32181569 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 928
Study 32181569 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 928
Study 32181569 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa inhibitors (GPI)
Number of subjects: 928
Study 36350567 — intervention group
Group type: EXPERIMENTAL
Intervention: Localization of MedlinePlus resources customized with community components
Number of subjects: 134
Study 36350567 — intervention group
Group type: COMPARATOR
Intervention: No localized community components (Control)
Number of subjects: 134
Study 34402665 — intervention group
Group type: EXPERIMENTAL
Intervention: Full prediction model based on clinical characteristics and MRI findings
Number of subjects: 454
Study 34402665 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model based solely on readily available MRI findings and age
Number of subjects: 454
Study 32330548 — intervention group
Group type: EXPERIMENTAL
Intervention: PE + MI
Number of subjects: 692
Study 32330548 — intervention group
Group type: EXPERIMENTAL
Intervention: PE + MI + RA
Number of subjects: 692
Study 35684140 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose eggshell membrane
Number of subjects: 0
Study 35684140 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose eggshell membrane
Number of subjects: 0
Study 35684140 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study 34952518 — intervention group
Group type: EXPERIMENTAL
Intervention: Interspinous process distraction devices (IPD) implantation
Number of subjects: 159
Study 34952518 — intervention group
Group type: COMPARATOR
Intervention: Spinal bony decompression
Number of subjects: 159
Study 32736299 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage supplemented with ora-pro-nobis (OPN) flour
Number of subjects: 24
Study 32736299 — intervention group
Group type: COMPARATOR
Intervention: Control group (same beverage without OPN)
Number of subjects: 24
Study 34047177 — intervention group
Group type: EXPERIMENTAL
Intervention: 6TG added to MTX/6MP maintenance therapy
Number of subjects: 30
Study 35659172 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (NIVO + IPI)
Number of subjects: 0
Study 35659172 — intervention group
Group type: COMPARATOR
Intervention: Platinum-doublet chemotherapy (PDC)
Number of subjects: 0
Study 34138468 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG (25 g/day for three days)
Number of subjects: 100
Study 32865577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-BA (behavioral activation) treatment delivered by lay counselors
Number of subjects: 277
Study 32865577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-PST (problem-solving therapy) delivered by licensed clinicians
Number of subjects: 277
Study 32865577 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (AC; telephone support calls)
Number of subjects: 277
Study 32865577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-BA vs Tele-PST
Number of subjects: 277
Study 34602412 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule Picolin (500 mg, two capsules thrice a day)
Number of subjects: 73
Study 34602412 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet Picolin-E (250 mg, thrice a day)
Number of subjects: 73
Study 34602412 — intervention group
Group type: COMPARATOR
Intervention: Metformin (500 mg, twice a day)
Number of subjects: 73
Study 34602412 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule Picolin
Number of subjects: 73
Study 34602412 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet Picolin-E
Number of subjects: 73
Study 34602412 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 73
Study 32603238 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports Stars intervention (8 weeks, 8 hours of physiotherapist-led training)
Number of subjects: 54
Study 32603238 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports Stars intervention
Number of subjects: 54
Study 32603238 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control group
Number of subjects: 54
Study 32447973 — intervention group
Group type: EXPERIMENTAL
Intervention: MDS 3.0 assessment of depression PHQ-9
Number of subjects: 446
Study 32447973 — intervention group
Group type: EXPERIMENTAL
Intervention: MDS 3.0 assessment of behavioral symptoms
Number of subjects: 446
Study 35439983 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram incorporating independent prognostic factors (age, AJCC 8th edition T, N and M stage, carcinoembryonic antigen (CEA), tumour differentiation, chemotherapy, perineural invasion, LNR)
Number of subjects: 8470
Study 35439983 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 8470
Study 32930057 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated intervention for PTSD and SUD (Seeking Safety)
Number of subjects: 226
Study 32930057 — intervention group
Group type: COMPARATOR
Intervention: Relapse prevention training (RPT)
Number of subjects: 226
Study 32102310 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based maternal nutritional education programme
Number of subjects: 110
Study 32102310 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 110
Study 34612583 — intervention group
Group type: COMPARATOR
Intervention: Upper blepharoplasty without orbicularis oculi muscle excision (group A)
Number of subjects: 54
Study 34612583 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper blepharoplasty with orbicularis oculi muscle excision (group B)
Number of subjects: 54